COSTEM 2019 | Immune reconstitution after HLA-HSCT

Leo Luznik

Leo Luznik, MD, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MA, discusses immune reconstitution after T-cell replete HLA-haploidentical transplantation (HLA-HSCT) at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  
Similar topics